Smith Nephew (UK) Today
| SN Stock | 1,108 64.00 6.13% |
PerformanceModest
| Odds Of DistressVery Small
|
Smith Nephew is trading at 1107.50 as of the 26th of February 2025, a 6.13 percent increase since the beginning of the trading day. The stock's lowest day price was 1063.0. Smith Nephew has a very small chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 16th of November 1999 | Category Healthcare | Classification Health Care |
Smith Nephew is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 872 M outstanding shares. More on Smith Nephew PLC
Moving against Smith Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Smith Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Smith Nephew's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Smith Nephew or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Smith Nephew's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Smith Nephew's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| President Operations | Paul Connolly | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care (View all Sectors) | ||||
| Excise Tax Activities | Animal Testing | ||||
Smith Nephew's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Smith Nephew's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsSmith Nephew can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Smith Nephew's financial leverage. It provides some insight into what part of Smith Nephew's total assets is financed by creditors.
| |||||
Smith Nephew PLC (SN) is traded on London Exchange in UK and employs 18,000 people. Smith Nephew is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.66 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Smith Nephew's market, we take the total number of its shares issued and multiply it by Smith Nephew's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Smith Nephew PLC operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 872 M outstanding shares.
Smith Nephew generates positive cash flow from operations, but has no cash available
Check Smith Nephew Probability Of Bankruptcy
Ownership AllocationSmith Nephew PLC shows a total of 872 Million outstanding shares. Over half of Smith Nephew's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Smith Nephew PLC. Please watch out for any change in the institutional holdings of Smith Nephew as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Smith Ownership Details
Smith Nephew PLC Risk Profiles
Although Smith Nephew's alpha and beta are two of the key measurements used to evaluate Smith Nephew's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.8289 | |||
| Semi Deviation | 0.7268 | |||
| Standard Deviation | 1.21 | |||
| Variance | 1.46 |
Smith Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Smith Nephew without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Smith Nephew Corporate Management
Elected by the shareholders, the Smith Nephew's board of directors comprises two types of representatives: Smith Nephew inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Smith. The board's role is to monitor Smith Nephew's management team and ensure that shareholders' interests are well served. Smith Nephew's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Smith Nephew's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alison Parkes | Chief Officer | Profile | |
| Deepak Nath | CEO Director | Profile | |
| Andrew Swift | Vice Relations | Profile | |
| AnneFrancoise Nesmes | CFO Director | Profile | |
| Helen Barraclough | Company Counsel | Profile | |
| Vasant Padmanabhan | Nose Ear | Profile |
Other Information on Investing in Smith Stock
Smith Nephew financial ratios help investors to determine whether Smith Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Smith with respect to the benefits of owning Smith Nephew security.